SCHEMBL159502

SCHEMBL159502

NC(=O)c1cc(O)[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165390 0.81 — —
SCHEMBL27452564 0.77 — —
SCHEMBL159501 0.77 — —
SCHEMBL4035315 0.77 — —
SCHEMBL1827221 0.77 MAPK1 (0.47) —
SCHEMBL4708946 0.77 — —
Potassium Ion SCHEMBL29224327 0.76 HCAR2 (0.41) —
SCHEMBL15556627 0.76 — —
SCHEMBL20029123 0.76 — —
SCHEMBL2629429 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040019046-A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents PHARMACIA ITALIA SPA (IT) 2004-01-29 — — US claimed
US-9856210-B2 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis KYOTO UNIVERSITY (JP) 2018-01-02 — — US disclosed
US-20170217901-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-4-CARBOXAMIDES SOLVAY SA (BE) 2017-08-03 — — US disclosed
EP-3174857-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-4-CARBOXAMIDES Solvay SA (BE) 2017-06-07 — — EP disclosed
EP-2611437-B1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS UNIV KYOTO (JP) 2017-03-29 — — EP disclosed
CN-102596913-B Cannabinoid receptor modulators 艾尼纳制药公司 2016-11-09 — — CN disclosed
WO-2016016298-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-4-CARBOXAMIDES SOLVAY SA (BE) 2016-02-04 — — WO disclosed
EP-2980078-A1 Process for the preparation of pyrazole-4-carboxamides Solvay SA (BE) 2016-02-03 — — EP disclosed
US-20130225642-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS KYOTO UNIVERSITY (JP) 2013-08-29 — — US disclosed
EP-2611437-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2013-07-10 — — EP disclosed
WO-2012029994-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS KYOTO UNIVERSITY (JP) 2012-03-08 — — WO disclosed
US-20040019046-A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents PHARMACIA ITALIA SPA (IT) 2004-01-29 — — US disclosed
EP-1345909-A1 PHENYLACETAMIDO-PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2003-09-24 — — EP disclosed
WO-2002048114-A1 PHENYLACETAMIDO- PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2002-06-20 — — WO disclosed
EP-0697623-B1 Silver halide photographic material containing pyrazolone-pentamethine oxonol dye FUJI PHOTO FILM CO LTD (JP) 1998-03-25 — — EP disclosed
US-5633390-A CONTROLLING LIGHT ABSORBED; CANBE BLEACHED OR DISSOVED IN PROCESSING SOLUTION; STABILITY FUJI PHOTO FILM CO., LTD. (JP) 1997-05-27 — — US disclosed
US-5563028-A DYES HAVE SPECIFIC SPECTRAL ABSORPTION, CHEMICAL INACTIVITY IN PHOTOGRAPHIC REACTIONS, BLEACHABLE OR DISSOLUTION, PHOTOSTABILITY AND COLORFASTNESS FUJI PHOTO FILM CO., LTD. (JP) 1996-10-08 — — US disclosed
EP-0697623-A1 Silver halide photographic material containing pyrazolone-pentamethine oxonol dye FUJI PHOTO FILM CO., LTD. (JP) 1996-02-21 — — EP disclosed
Send feedback